Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | JNJ | ZBH |
|---|
| Close | 267.28 | 96.78 |
| Market Cap | $644B | $18.4B |
| 1M | +1.87% | −1.45% |
| P/E (TTM) | 30.6 | 22.1 |
| Forward P/E | 20.7 | 10.8 |
| P/E 5-Yr Percentile | 90 | 25 |
| P/S | 6.6 | 2.1 |
| P/B | 7.6 | 1.4 |
| Dividend Yield | 3.12% | 1.04% |
| Latest Quarter Revenue | $25.3B | $2.2B |
| Revenue YoY | +6.6% | +4.8% |
| Gross Margin | 68.2% | 70.8% |
| Latest Quarter EPS | 2.27 | 1.03 |
| Avg Post-Earnings Move | ±0.6% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.25% | 5.11% |
| 90-Day Net Insider Buying | −$67.8M | −$0.82M |
JNJ · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
